These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11252946)

  • 1. [Thyroid cancers. Pathology, diagnosis].
    Wemeau JL
    Rev Prat; 2001 Jan; 51(2):187-91. PubMed ID: 11252946
    [No Abstract]   [Full Text] [Related]  

  • 2. Empirically treating high serum thyroglobulin levels.
    Mazzaferri EL
    J Nucl Med; 2005 Jul; 46(7):1079-88. PubMed ID: 16000275
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of recombinant thyrotropin.
    Toft A; Beckett G
    Lancet; 2002 Jun; 359(9321):1874-5. PubMed ID: 12057547
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroglobulin before ablative radioiodine therapy.
    Grünwald F; Menzel C; Biersack HJ
    Eur J Nucl Med; 2000 Apr; 27(4):461. PubMed ID: 10805121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant goiter].
    Fischer M; Buttermann G; Becker G; Hör G; Theisinger W
    Fortschr Med; 1973 Oct; 91(29):1159-64. PubMed ID: 4748917
    [No Abstract]   [Full Text] [Related]  

  • 8. Contemporary management of papillary carcinoma of the thyroid gland.
    Rosenbaum MA; McHenry CR
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary thyroid carcinoma in a 3-year-old child: case report.
    Alkan S; Seven H; Sakalli E; Dadaş B
    Int J Pediatr Otorhinolaryngol; 2008 Feb; 72(2):275-7. PubMed ID: 18061281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for the management of differentiated thyroid cancers].
    Ann Endocrinol (Paris); 2007 Dec; 68 Suppl 2():S57-72. PubMed ID: 18342281
    [No Abstract]   [Full Text] [Related]  

  • 12. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
    Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
    Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
    Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
    Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
    Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
    Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid nodules and cancers in children.
    Josefson J; Zimmerman D
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):14-23. PubMed ID: 18806721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differentiated thyroid cancers].
    Gorgone S; Campennì A; Calbo E; Catalfamo A; Sciglitano P; Sofia L; Niceta M; Borzì R; Calbo L
    G Chir; 2009; 30(1-2):26-9. PubMed ID: 19272228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid carcinoma.
    Tuttle RM; Ball DW; Byrd D; Dilawari RA; Doherty GM; Duh QY; Ehya H; Farrar WB; Haddad RI; Kandeel F; Kloos RT; Kopp P; Lamonica DM; Loree TR; Lydiatt WM; McCaffrey JC; Olson JA; Parks L; Ridge JA; Shah JP; Sherman SI; Sturgeon C; Waguespack SG; Wang TN; Wirth LJ;
    J Natl Compr Canc Netw; 2010 Nov; 8(11):1228-74. PubMed ID: 21081783
    [No Abstract]   [Full Text] [Related]  

  • 19. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
    Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
    Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.